EUVIMEDEUVIMED entdecken
Open Access

Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections

Andrew Bock, Blake M Hanson, Felicia Ruffin, Joshua B Parsons, Lawrence P Park, Batu Sharma-Kuinkel, Michael Mohnasky, Cesar A Arias, Vance G Fowler, Joshua T Thaden

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · e1285-e1293

DOI: 10.1093/cid/ciac638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 05.08.2022. Verfasst von Andrew Bock und 9 weiteren Autor:innen. Beteiligte Einrichtung: Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Bacteremia, Gram-Negative Bacterial Infections, Sepsis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The causes and clinical characteristics of recurrent gram-negative bacterial bloodstream infections (GNB-BSI) are poorly understood.

Methods

We used a cohort of patients with GNB-BSI to identify clinical characteristics, microbiology, and risk factors associated with recurrent GNB-BSI. Bacterial genotyping (pulsed-field gel electrophoresis [PFGE] and whole-genome sequencing [WGS]) was used to determine whether episodes were due to relapse or reinfection. Multivariable logistic regression was used to identify risk factors for recurrence.

Results

Of the 1423 patients with GNB-BSI in this study, 60 (4%) had recurrent GNB-BSI. Non-White race (odds ratio [OR], 2.35; 95% confidence interval [CI], 1.38–4.01; P = .002), admission to a surgical service (OR, 2.18; 95% CI, 1.26–3.75; P = .005), and indwelling cardiac device (OR, 2.73; 95% CI, 1.21–5.58; P = .009) were associated with increased risk for recurrent GNB-BSI. Among the 48 patients with recurrent GNB-BSI whose paired bloodstream isolates underwent genotyping, 63% were due to relapse (30 of 48) and 38% were due to reinfection (18 of 48) based on WGS. Compared with WGS, PFGE correctly differentiated relapse and reinfection in 98% (47 of 48) of cases. Median time to relapse and reinfection was similar (113 days; interquartile range [IQR], 35–222 vs 174 days; IQR, 69–599; P = .13). Presence of a cardiac device was associated with relapse (relapse: 7 of 27, 26%; nonrelapse: 65 of 988, 7%; P = .002).

Conclusions

In this study, recurrent GNB-BSI was most commonly due to relapse. PFGE accurately differentiated relapse from reinfection when compared with WGS. Cardiac device was a risk factor for relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaGram-Negative Bacterial InfectionsSepsisHumansReinfectionRecurrenceRisk FactorsRetrospective Studies

Stichwörter der Autor:innen

bacteremiabloodstream infectiongram-negativerecurrent

Autor:innen und Institutionen

  • Duke University School of Medicine, Durham, North Carolina, USA.
  • Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.
  • Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
  • Division of Infectious Disease, Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
  • Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Duke Global Health Institute, Durham, North Carolina, USA.

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Bock, A., Hanson, B. M., Ruffin, F., Parsons, J. B., Park, L. P., Sharma-Kuinkel, B., Mohnasky, M., Arias, C. A., Fowler, V. G., & Thaden, J. T. (2023). Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections. Clinical Infectious Diseases, 76(3), e1285-e1293. https://doi.org/10.1093/cid/ciac638

Vancouver

Bock A, Hanson BM, Ruffin F, Parsons JB, Park LP, Sharma-Kuinkel B, et al. Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections. Clinical Infectious Diseases. 2023;76(3):e1285-e1293. doi:10.1093/cid/ciac638

BibTeX
@article{Bock2023,
  author = {Bock, Andrew and Hanson, Blake M and Ruffin, Felicia and Parsons, Joshua B and Park, Lawrence P and Sharma-Kuinkel, Batu and Mohnasky, Michael and Arias, Cesar A and Fowler, Vance G and Thaden, Joshua T},
  title = {Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {e1285--e1293},
  doi = {10.1093/cid/ciac638}
}
Kostenlos starten →